Apple David J
Medical University of South Carolina, Storm Eye Institute.
Biogr Mem Fellows R Soc. 2007;53:285-307. doi: 10.1098/rsbm.2007.0022.
Sir Harold Ridley invented and refined the modern miracle of replacing lenses obscured by cataracts with plastic optical lenses, thus rendering a complete cataract cure. This operation, broadly termed the cataract-intraocular lens (IOL) operation, has since brought sight to many millions of people throughout the world, and continues to improve the quality of life of more than 10 million patients worldwide each year. Ridley not only launched this powerful and irreversible forward movement in the field of ophthalmology and the visual sciences, but through it he also helped give birth to the exciting and new field of artificial biodevice implantation as well as transplantation techniques now applied to many other organs and tissues of the body. He has therefore been credited with healing to create the relatively new specialty of biomedical engineering. Few of the millions of patients worldwide who now enjoy the benefits of the modern cataract - IOL operation are aware of the origin of this innovation. Indeed, few eye care professionals - even ophthalmic surgeons who implant them almost daily - are aware of the origin of the IOL - an invention that, as Harold himself liked to say, 'cured aphakia'. (The word aphakia comes from teh Greek, meaning absence of lens, the situation that occurs when a cataractous lens is surgically removed.)
哈罗德·里德利爵士发明并完善了一项现代奇迹:用塑料光学镜片替换因白内障而模糊的晶状体,从而实现了白内障的彻底治愈。这项手术,广义上称为白内障人工晶状体(IOL)手术,自此为全世界数百万人带来了光明,并继续每年改善全球超过1000万患者的生活质量。里德利不仅在眼科和视觉科学领域发起了这一强大且不可逆转的进步运动,而且通过它还催生了令人兴奋的人工生物装置植入新领域以及如今应用于身体许多其他器官和组织的移植技术。因此,他被誉为开创了生物医学工程这一相对较新的专业。全球数百万如今受益于现代白内障-IOL手术的患者中,很少有人知道这项创新的起源。事实上,很少有眼保健专业人员——甚至几乎每天都在植入人工晶状体的眼科外科医生——了解IOL的起源,而哈罗德本人喜欢说,这项发明“治愈了无晶状体症”。(“无晶状体症”一词来自希腊语,意为晶状体缺失,即白内障晶状体被手术摘除时出现的情况。)